Clinical Trial Update: Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rosuvastatin for vascular protection in arteriovenous fistula among patients with end-stage kidney disease and diabetes; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• End-stage Kidney Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: End-stage Kidney Disease, Diabetes Mellitus | Phase 2 | Status: COMPLETED